• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在一名免疫抑制个体中进化出增加的感染引发的细胞死亡和融合。

SARS-CoV-2 evolves increased infection elicited cell death and fusion in an immunosuppressed individual.

作者信息

Lustig Gila, Ganga Yashica, Rodel Hylton, Tegally Houriiyah, Jackson Laurelle, Cele Sandile, Khan Khadija, Jule Zesuliwe, Reedoy Kajal, Karim Farina, Bernstein Mallory, Moosa Mahomed-Yunus S, Archary Derseree, de Oliveira Tulio, Lessells Richard, Abdool Karim Salim S, Sigal Alex

机构信息

Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.

Africa Health Research Institute, Durban, South Africa.

出版信息

medRxiv. 2022 Nov 30:2022.11.23.22282673. doi: 10.1101/2022.11.23.22282673.

DOI:10.1101/2022.11.23.22282673
PMID:36451879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9709797/
Abstract

The milder clinical manifestations of Omicron infection relative to pre-Omicron SARS CoV-2 raises the possibility that extensive evolution results in reduced pathogenicity. To test this hypothesis, we quantified induction of cell fusion and cell death in SARS CoV-2 evolved from ancestral virus during long-term infection. Both cell fusion and death were reduced in Omicron BA.1 infection relative to ancestral virus. Evolved virus was isolated at different times during a 6-month infection in an immunosuppressed individual with advanced HIV disease. The virus isolated 16 days post-reported symptom onset induced fusogenicity and cell death at levels similar to BA.1. However, fusogenicity was increased in virus isolated at 6 months post-symptoms to levels intermediate between BA.1 and ancestral SARS-CoV-2. Similarly, infected cell death showed a graded increase from earlier to later isolates. These results may indicate that, at least by the cellular measures used here, evolution in long-term infection does not necessarily attenuate the virus.

摘要

与奥密克戎之前的新冠病毒相比,奥密克戎感染的临床表现较轻,这增加了广泛进化导致致病性降低的可能性。为了验证这一假设,我们对长期感染过程中从原始病毒进化而来的新冠病毒诱导细胞融合和细胞死亡的情况进行了量化。与原始病毒相比,奥密克戎BA.1感染中细胞融合和死亡均减少。在一名患有晚期艾滋病的免疫抑制个体的6个月感染期间,在不同时间分离出进化病毒。报告症状出现后16天分离出的病毒诱导融合性和细胞死亡的水平与BA.1相似。然而,症状出现后6个月分离出的病毒的融合性增加到介于BA.1和原始新冠病毒之间的水平。同样,受感染细胞死亡从早期到晚期分离株呈逐渐增加趋势。这些结果可能表明,至少就此处所采用的细胞检测方法而言,长期感染中的进化不一定会使病毒减弱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a30/9749530/6fd53f682252/nihpp-2022.11.23.22282673v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a30/9749530/6c4fe4afd2ba/nihpp-2022.11.23.22282673v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a30/9749530/5a3f215df932/nihpp-2022.11.23.22282673v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a30/9749530/4b4ad9df132f/nihpp-2022.11.23.22282673v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a30/9749530/6fd53f682252/nihpp-2022.11.23.22282673v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a30/9749530/6c4fe4afd2ba/nihpp-2022.11.23.22282673v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a30/9749530/5a3f215df932/nihpp-2022.11.23.22282673v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a30/9749530/4b4ad9df132f/nihpp-2022.11.23.22282673v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a30/9749530/6fd53f682252/nihpp-2022.11.23.22282673v2-f0004.jpg

相似文献

1
SARS-CoV-2 evolves increased infection elicited cell death and fusion in an immunosuppressed individual.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在一名免疫抑制个体中进化出增加的感染引发的细胞死亡和融合。
medRxiv. 2022 Nov 30:2022.11.23.22282673. doi: 10.1101/2022.11.23.22282673.
2
The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection.SARS-CoV-2 刺突蛋白是一种毒力决定因素,在感染猫模型中对奥密克戎病毒的衰减表型起主要作用。
J Virol. 2024 Mar 19;98(3):e0190223. doi: 10.1128/jvi.01902-23. Epub 2024 Feb 29.
3
SARS-CoV-2 infection in immunosuppression evolves sub-lineages which independently accumulate neutralization escape mutations.免疫抑制状态下的新型冠状病毒2型感染会演变出亚谱系,这些亚谱系会独立积累中和逃逸突变。
Virus Evol. 2023 Dec 28;10(1):vead075. doi: 10.1093/ve/vead075. eCollection 2024.
4
Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study.新冠病毒感染后症状患者中,新冠病毒(SARS-CoV-2)的病毒动力学:对香港感染原始株和奥密克戎 BA.2 患者的回顾性观察研究。
Lancet Microbe. 2023 Sep;4(9):e722-e731. doi: 10.1016/S2666-5247(23)00146-5.
5
Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections.在原始或奥密克戎 BA.1 SARS-CoV-2 感染期间的病毒脱落动力学,以及在突破感染期间增强预先存在的免疫。
Emerg Microbes Infect. 2022 Dec;11(1):2423-2432. doi: 10.1080/22221751.2022.2122578.
6
Potent inhibition of diverse Omicron sublineages by SARS-CoV-2 fusion-inhibitory lipopeptides.SARS-CoV-2 融合抑制性脂肽对多种奥密克戎亚谱系的强效抑制作用。
Antiviral Res. 2022 Dec;208:105445. doi: 10.1016/j.antiviral.2022.105445. Epub 2022 Oct 17.
7
Ancestral SARS-CoV-2 and Omicron BA.5-specific neutralizing antibody and T-cell responses after Omicron bivalent booster vaccination in previously infected and infection-naive individuals.先前感染和未感染个体接种奥密克戎二价加强针后针对原始 SARS-CoV-2 和奥密克戎 BA.5 的中和抗体和 T 细胞应答。
J Med Virol. 2023 Aug;95(8):e28989. doi: 10.1002/jmv.28989.
8
Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages.SARS-CoV-2 刺突蛋白的适应性变异:对不同病毒-细胞进入阶段的影响。
mBio. 2023 Aug 31;14(4):e0017123. doi: 10.1128/mbio.00171-23. Epub 2023 Jun 29.
9
SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors.SARS-CoV-2 奥密克戎亚变体对泛冠状病毒融合抑制剂表现出不同的融合性,但敏感性相似。
Emerg Microbes Infect. 2023 Dec;12(1):2178241. doi: 10.1080/22221751.2023.2178241.
10
Anti-SARS-CoV-2 serology based on ancestral RBD antigens does not correlate with the presence of neutralizing antibodies against Omicron variants.基于原始受体结合域(RBD)抗原的抗严重急性呼吸综合征冠状病毒2(SARS-CoV-2)血清学与针对奥密克戎变异株的中和抗体的存在不相关。
Microbiol Spectr. 2025 Jan 7;13(1):e0156824. doi: 10.1128/spectrum.01568-24. Epub 2024 Nov 20.

本文引用的文献

1
Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England.英格兰一项针对 1542510 名成年人的研究显示了 COVID-19 的变异特异性症状。
Nat Commun. 2022 Nov 11;13(1):6856. doi: 10.1038/s41467-022-34244-2.
2
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5.SARS-CoV-2 奥密克戎 BA.2 亚系,包括 BA.4 和 BA.5 的病毒学特征。
Cell. 2022 Oct 13;185(21):3992-4007.e16. doi: 10.1016/j.cell.2022.09.018. Epub 2022 Sep 14.
3
Recurrent SARS-CoV-2 mutations in immunodeficient patients.
免疫缺陷患者中出现的新冠病毒(SARS-CoV-2)复发性突变
Virus Evol. 2022 Aug 11;8(2):veac050. doi: 10.1093/ve/veac050. eCollection 2022 Jul.
4
Risk of covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with delta (B.1.617.2): retrospective cohort study.奥密克戎(B.1.1.529)与德尔塔(B.1.617.2)相关的 COVID-19 死亡风险比较:回顾性队列研究。
BMJ. 2022 Aug 2;378:e070695. doi: 10.1136/bmj-2022-070695.
5
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines.奥密克戎刺突功能和中和活性由一组全面的疫苗引发。
Science. 2022 Aug 19;377(6608):890-894. doi: 10.1126/science.abq0203. Epub 2022 Jul 19.
6
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway.SARS-CoV-2 奥密克戎是一种具有改变的细胞进入途径的免疫逃逸变体。
Nat Microbiol. 2022 Aug;7(8):1161-1179. doi: 10.1038/s41564-022-01143-7. Epub 2022 Jul 7.
7
Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection With accumulation of mutations in a patient with poorly controlled Human Immunodeficiency Virus infection.持续性严重急性呼吸系统综合征冠状病毒 2 感染,伴有 HIV 感染控制不佳的患者体内病毒突变的积累。
Clin Infect Dis. 2023 Feb 8;76(3):e522-e525. doi: 10.1093/cid/ciac548.
8
Therapy Targets SARS-CoV-2 Infection-Induced Cell Death.治疗靶点:SARS-CoV-2 感染诱导的细胞死亡。
Front Immunol. 2022 May 17;13:870216. doi: 10.3389/fimmu.2022.870216. eCollection 2022.
9
Generation of Novel Severe Acute Respiratory Syndrome Coronavirus 2 Variants on the B.1.1.7 Lineage in 3 Patients With Advanced Human Immunodeficiency Virus-1 Disease.3 例晚期人类免疫缺陷病毒-1 病患者中 B.1.1.7 谱系新型严重急性呼吸综合征冠状病毒 2 变异株的产生。
Clin Infect Dis. 2022 Nov 30;75(11):2016-2018. doi: 10.1093/cid/ciac409.
10
Omicron infection enhances Delta antibody immunity in vaccinated persons.奥密克戎感染可增强接种者体内针对德尔塔变异株的抗体免疫。
Nature. 2022 Jul;607(7918):356-359. doi: 10.1038/s41586-022-04830-x. Epub 2022 May 6.